Beyond PVR: A Dual-Branch Parallel-Resistance Model Integrating Intrapulmonary Arteriovenous Anastomoses and Gas Exchange
- 1Research Department, E.S.C.O.T.-Europe, 20841 Carate Brianza, Italy
Abstract
Evaluating drug efficacy in pulmonary hypertension (PH) relies on decreased pulmonary vascular resistance (PVR), which can be misleading if the role of intrapulmonary arteriovenous anastomoses (IPAVA) is neglected. In this secondary, cross-cohort computational reanalysis of experimental data from healthy subjects, pulmonary circulation with open IPAVA was modeled as a parallel circuit featuring model-derived branch resistance—exchanging pathway resistance (RQ˙p) and IPAVA resistance (RQ˙IPAVA)—to establish a dual-branch parallel framework. This model was evaluated against acetazolamide (ACZ) vs placebo experimental data during hypoxia (FIO2 = 0.125) at rest and during heavy exercise under normoxia. Under resting hypoxia, ACZ decreased PVR (−0.25 WU vs. placebo), but there was a marked concomitant decrease in RQ˙IPAVA (−21.47 WU), which masked an underlying increase in RQ˙p (+ 0.15 WU) and a reduction in capillary flow (Q˙p = −1.08 L/min). Despite the lower expired V˙CO2, the microvascular CO2 extraction efficiency (ϵ =V˙CO2/Q˙p) increased by 16.8% under ACZ. During heavy normoxic exercise, ACZ increased the shunt fraction (Q˙IPAVA/Q˙T) from 2.4% to ~15% of cardiac output (Q˙T), reducing Q˙p by 11.3% and V˙CO2 by 8.7%, whereas ϵ remained stable (+ 3.0% under ACZ). The stability or increase in ϵ supports the hypothesis that reduced expired V˙CO2 is driven by microvascular flow diversion (Q˙p ↓, Q˙IPAVA ↑) rather than enzymatic carbonic anhydrase inhibition. Evaluating drug efficacy solely on the basis of PVR may provide an incomplete assessment of microvascular flow perfusion. Integrating hemodynamic parameters with Lavoisier’s mass balance offers a testable computational model to distinguish functional capillary perfusion from bypass recruitment in pulmonary vascular research.
Related
- Insights into human cardiac lipid dynamics through comprehensive arteriovenous lipidomics
- Enhancing double-duplex invasion by using multiple parallel-stranded peptide nucleic acids
- Parallel Production of Uniform Artificial Multicellular Models Using Vibration-Induced Local Microvortices
- Clonal lineage tracing and parallel multiomics profiling reveal transcriptional heterogeneity induced by ARID1A deficiency
- Myosin-X sorts actin filaments into parallel bundles and tunes barbed-end dynamics
BibTeX
@article{vanni2026beyond,
title = {{Beyond PVR: A Dual-Branch Parallel-Resistance Model Integrating Intrapulmonary Arteriovenous Anastomoses and Gas Exchange}},
author = {Rosalba Vanni},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210221},
url = {https://www.mdpi.com/1422-0067/27/22/10221},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Beyond PVR: A Dual-Branch Parallel-Resistance Model Integrating Intrapulmonary Arteriovenous Anastomoses and Gas Exchange
AU - Rosalba Vanni
PY - 2026
DA - 2026/11/14
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210221
UR - https://www.mdpi.com/1422-0067/27/22/10221
AB - Evaluating drug efficacy in pulmonary hypertension (PH) relies on decreased pulmonary vascular resistance (PVR), which can be misleading if the role of intrapulmonary arteriovenous anastomoses (IPAVA) is neglected. In this secondary, cross-cohort computational reanalysis of experimental data from healthy subjects, pulmonary circulation with open IPAVA was modeled as a parallel circuit featuring model-derived branch resistance—exchanging pathway resistance (RQ˙p) and IPAVA resistance (RQ˙IPAVA)—to establish a dual-branch parallel framework. This model was evaluated against acetazolamide (ACZ) vs placebo experimental data during hypoxia (FIO2 = 0.125) at rest and during heavy exercise under normoxia. Under resting hypoxia, ACZ decreased PVR (−0.25 WU vs. placebo), but there was a marked concomitant decrease in RQ˙IPAVA (−21.47 WU), which masked an underlying increase in RQ˙p (+ 0.15 WU) and a reduction in capillary flow (Q˙p = −1.08 L/min). Despite the lower expired V˙CO2, the microvascular CO2 extraction efficiency (ϵ =V˙CO2/Q˙p) increased by 16.8% under ACZ. During heavy normoxic exercise, ACZ increased the shunt fraction (Q˙IPAVA/Q˙T) from 2.4% to ~15% of cardiac output (Q˙T), reducing Q˙p by 11.3% and V˙CO2 by 8.7%, whereas ϵ remained stable (+ 3.0% under ACZ). The stability or increase in ϵ supports the hypothesis that reduced expired V˙CO2 is driven by microvascular flow diversion (Q˙p ↓, Q˙IPAVA ↑) rather than enzymatic carbonic anhydrase inhibition. Evaluating drug efficacy solely on the basis of PVR may provide an incomplete assessment of microvascular flow perfusion. Integrating hemodynamic parameters with Lavoisier’s mass balance offers a testable computational model to distinguish functional capillary perfusion from bypass recruitment in pulmonary vascular research.
SN - 1422-0067
ER -